Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology.

Ide M, Ohnishi T, Toyoshima M, Balan S, Maekawa M, Shimamoto-Mitsuyama C, Iwayama Y, Ohba H, Watanabe A, Ishii T, Shibuya N, Kimura Y, Hisano Y, Murata Y, Hara T, Morikawa M, Hashimoto K, Nozaki Y, Toyota T, Wada Y, Tanaka Y, Kato T, Nishi A, Fujisawa S, Okano H, Itokawa M, Hirokawa N, Kunii Y, Kakita A, Yabe H, Iwamoto K, Meno K, Katagiri T, Dean B, Uchida K, Kimura H, Yoshikawa T.

EMBO Mol Med. 2019 Dec;11(12):e10695. doi: 10.15252/emmm.201910695. Epub 2019 Oct 28.

2.

Investigation of betaine as a novel psychotherapeutic for schizophrenia.

Ohnishi T, Balan S, Toyoshima M, Maekawa M, Ohba H, Watanabe A, Iwayama Y, Fujita Y, Tan Y, Hisano Y, Shimamoto-Mitsuyama C, Nozaki Y, Esaki K, Nagaoka A, Matsumoto J, Hino M, Mataga N, Hayashi-Takagi A, Hashimoto K, Kunii Y, Kakita A, Yabe H, Yoshikawa T.

EBioMedicine. 2019 Jul;45:432-446. doi: 10.1016/j.ebiom.2019.05.062. Epub 2019 Jun 26.

3.

Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation.

Ma M, Ren Q, Yang J, Zhang K, Xiong Z, Ishima T, Pu Y, Hwang SH, Toyoshima M, Iwayama Y, Hisano Y, Yoshikawa T, Hammock BD, Hashimoto K.

Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7083-7088. doi: 10.1073/pnas.1819234116. Epub 2019 Mar 19.

4.

Evaluation of the role of fatty acid-binding protein 7 in controlling schizophrenia-relevant phenotypes using newly established knockout mice.

Shimamoto-Mitsuyama C, Ohnishi T, Balan S, Ohba H, Watanabe A, Maekawa M, Hisano Y, Iwayama Y, Owada Y, Yoshikawa T.

Schizophr Res. 2019 Feb 11. pii: S0920-9964(19)30052-0. doi: 10.1016/j.schres.2019.02.002. [Epub ahead of print]

PMID:
30765249
5.

Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.

Ikeda M, Takahashi A, Kamatani Y, Momozawa Y, Saito T, Kondo K, Shimasaki A, Kawase K, Sakusabe T, Iwayama Y, Toyota T, Wakuda T, Kikuchi M, Kanahara N, Yamamori H, Yasuda Y, Watanabe Y, Hoya S, Aleksic B, Kushima I, Arai H, Takaki M, Hattori K, Kunugi H, Okahisa Y, Ohnuma T, Ozaki N, Someya T, Hashimoto R, Yoshikawa T, Kubo M, Iwata N.

Schizophr Bull. 2019 Jun 18;45(4):824-834. doi: 10.1093/schbul/sby140.

PMID:
30285260
6.

Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine.

Shima H, Kutomi G, Satomi F, Imamura M, Kimura Y, Mizuguchi T, Watanabe K, Takahashi A, Murai A, Tsukahara T, Kanaseki T, Hirohashi Y, Iwayama Y, Tsuruma T, Kameshima H, Sato N, Torigoe T, Takemasa I.

Cancer Immunol Immunother. 2018 Oct;67(10):1603-1609. doi: 10.1007/s00262-018-2217-x. Epub 2018 Aug 1.

7.

Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis.

Tomioka Y, Numata S, Kinoshita M, Umehara H, Watanabe SY, Nakataki M, Iwayama Y, Toyota T, Ikeda M, Yamamori H, Shimodera S, Tajima A, Hashimoto R, Iwata N, Yoshikawa T, Ohmori T.

J Psychiatry Neurosci. 2018 May;43(3):194-200.

8.

Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis.

Tomioka Y, Numata S, Kinoshita M, Umehara H, Watanabe SY, Nakataki M, Iwayama Y, Toyota T, Ikeda M, Yamamori H, Shimodera S, Tajima A, Hashimoto R, Iwata N, Yoshikawa T, Ohmori T.

J Psychiatry Neurosci. 2018 Feb 2;43(2):170053. doi: 10.1503/jpn.170053. [Epub ahead of print]

9.

Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation.

Matsuura A, Ishima T, Fujita Y, Iwayama Y, Hasegawa S, Kawahara-Miki R, Maekawa M, Toyoshima M, Ushida Y, Suganuma H, Kida S, Yoshikawa T, Iyo M, Hashimoto K.

Sci Rep. 2018 Feb 1;8(1):2158. doi: 10.1038/s41598-018-20538-3.

10.

Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population.

Kobayashi M, Jitoku D, Iwayama Y, Yamamoto N, Toyota T, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Kurumaji A, Yoshikawa T, Nishikawa T.

PLoS One. 2018 Jan 8;13(1):e0190991. doi: 10.1371/journal.pone.0190991. eCollection 2018.

11.

Genetic and molecular risk factors within the newly identified primate-specific exon of the SAP97/DLG1 gene in the 3q29 schizophrenia-associated locus.

Uezato A, Yamamoto N, Jitoku D, Haramo E, Hiraaki E, Iwayama Y, Toyota T, Umino M, Umino A, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Kurumaji A, Yoshikawa T, Nishikawa T.

Am J Med Genet B Neuropsychiatr Genet. 2017 Dec;174(8):798-807. doi: 10.1002/ajmg.b.32595. Epub 2017 Oct 9.

PMID:
28990294
12.

A novel rare variant R292H in RTN4R affects growth cone formation and possibly contributes to schizophrenia susceptibility.

Kimura H, Fujita Y, Kawabata T, Ishizuka K, Wang C, Iwayama Y, Okahisa Y, Kushima I, Morikawa M, Uno Y, Okada T, Ikeda M, Inada T, Branko A, Mori D, Yoshikawa T, Iwata N, Nakamura H, Yamashita T, Ozaki N.

Transl Psychiatry. 2017 Aug 22;7(8):e1214. doi: 10.1038/tp.2017.170.

13.

Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes.

Maekawa M, Watanabe A, Iwayama Y, Kimura T, Hamazaki K, Balan S, Ohba H, Hisano Y, Nozaki Y, Ohnishi T, Toyoshima M, Shimamoto C, Iwamoto K, Bundo M, Osumi N, Takahashi E, Takashima A, Yoshikawa T.

Transl Psychiatry. 2017 Sep 5;7(9):e1229. doi: 10.1038/tp.2017.182.

14.

Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders.

Ishizuka K, Fujita Y, Kawabata T, Kimura H, Iwayama Y, Inada T, Okahisa Y, Egawa J, Usami M, Kushima I, Uno Y, Okada T, Ikeda M, Aleksic B, Mori D, Someya T, Yoshikawa T, Iwata N, Nakamura H, Yamashita T, Ozaki N.

Transl Psychiatry. 2017 Aug 1;7(8):e1184. doi: 10.1038/tp.2017.173.

15.

Autism-like behaviours and enhanced memory formation and synaptic plasticity in Lrfn2/SALM1-deficient mice.

Morimura N, Yasuda H, Yamaguchi K, Katayama KI, Hatayama M, Tomioka NH, Odagawa M, Kamiya A, Iwayama Y, Maekawa M, Nakamura K, Matsuzaki H, Tsujii M, Yamada K, Yoshikawa T, Aruga J.

Nat Commun. 2017 Jun 12;8:15800. doi: 10.1038/ncomms15800.

16.

Comprehensive association analysis of 27 genes from the GABAergic system in Japanese individuals affected with schizophrenia.

Balan S, Yamada K, Iwayama Y, Hashimoto T, Toyota T, Shimamoto C, Maekawa M, Takagai S, Wakuda T, Kameno Y, Kurita D, Yamada K, Kikuchi M, Hashimoto T, Kanahara N, Yoshikawa T.

Schizophr Res. 2017 Jul;185:33-40. doi: 10.1016/j.schres.2017.01.003. Epub 2017 Jan 7.

PMID:
28073605
17.

A spontaneous and novel Pax3 mutant mouse that models Waardenburg syndrome and neural tube defects.

Ohnishi T, Miura I, Ohba H, Shimamoto C, Iwayama Y, Wakana S, Yoshikawa T.

Gene. 2017 Apr 5;607:16-22. doi: 10.1016/j.gene.2016.12.037. Epub 2016 Dec 30.

PMID:
28043919
18.

Age-Dependent Effects of Catechol-O-Methyltransferase (COMT) Gene Val158Met Polymorphism on Language Function in Developing Children.

Sugiura L, Toyota T, Matsuba-Kurita H, Iwayama Y, Mazuka R, Yoshikawa T, Hagiwara H.

Cereb Cortex. 2017 Jan 1;27(1):104-116. doi: 10.1093/cercor/bhw371.

19.

Analysis of induced pluripotent stem cells carrying 22q11.2 deletion.

Toyoshima M, Akamatsu W, Okada Y, Ohnishi T, Balan S, Hisano Y, Iwayama Y, Toyota T, Matsumoto T, Itasaka N, Sugiyama S, Tanaka M, Yano M, Dean B, Okano H, Yoshikawa T.

Transl Psychiatry. 2016 Nov 1;6(11):e934. doi: 10.1038/tp.2016.206.

20.

Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis.

Yoshimi N, Futamura T, Bergen SE, Iwayama Y, Ishima T, Sellgren C, Ekman CJ, Jakobsson J, Pålsson E, Kakumoto K, Ohgi Y, Yoshikawa T, Landén M, Hashimoto K.

Mol Psychiatry. 2016 Nov;21(11):1504-1510. doi: 10.1038/mp.2015.217. Epub 2016 Jan 19.

21.

Mutation screening of GRIN2B in schizophrenia and autism spectrum disorder in a Japanese population.

Takasaki Y, Koide T, Wang C, Kimura H, Xing J, Kushima I, Ishizuka K, Mori D, Sekiguchi M, Ikeda M, Aizawa M, Tsurumaru N, Iwayama Y, Yoshimi A, Arioka Y, Yoshida M, Noma H, Oya-Ito T, Nakamura Y, Kunimoto S, Aleksic B, Uno Y, Okada T, Ujike H, Egawa J, Kuwabara H, Someya T, Yoshikawa T, Iwata N, Ozaki N.

Sci Rep. 2016 Sep 12;6:33311. doi: 10.1038/srep33311.

22.

Erratum: Investigation of the fatty acid transporter-encoding genes SLC27A3 and SLC27A4 in autism.

Maekawa M, Iwayama Y, Ohnishi T, Toyoshima M, Shimamoto C, Hisano Y, Toyota T, Balan S, Matsuzaki H, Iwata Y, Takagai S, Yamada K, Ota M, Fukuchi S, Okada Y, Akamatsu W, Tsujii M, Kojima N, Owada Y, Okano H, Mori N, Yoshikawa T.

Sci Rep. 2016 Jan 29;6:20268. doi: 10.1038/srep20268. No abstract available.

23.

Fatty acid composition and fatty acid binding protein expression in the postmortem frontal cortex of patients with schizophrenia: A case-control study.

Hamazaki K, Maekawa M, Toyota T, Iwayama Y, Dean B, Hamazaki T, Yoshikawa T.

Schizophr Res. 2016 Mar;171(1-3):225-32. doi: 10.1016/j.schres.2016.01.014. Epub 2016 Jan 17.

PMID:
26792082
24.

Investigation of the fatty acid transporter-encoding genes SLC27A3 and SLC27A4 in autism.

Maekawa M, Iwayama Y, Ohnishi T, Toyoshima M, Shimamoto C, Hisano Y, Toyota T, Balan S, Matsuzaki H, Iwata Y, Takagai S, Yamada K, Ota M, Fukuchi S, Okada Y, Akamatsu W, Tsujii M, Kojima N, Owada Y, Okano H, Mori N, Yoshikawa T.

Sci Rep. 2015 Nov 9;5:16239. doi: 10.1038/srep16239. Erratum in: Sci Rep. 2016;6:20268.

25.

Reduced cortical expression of a newly identified splicing variant of the DLG1 gene in patients with early-onset schizophrenia.

Uezato A, Yamamoto N, Iwayama Y, Hiraoka S, Hiraaki E, Umino A, Haramo E, Umino M, Yoshikawa T, Nishikawa T.

Transl Psychiatry. 2015 Oct 6;5:e654. doi: 10.1038/tp.2015.154.

26.

Population-dependent contribution of the major histocompatibility complex region to schizophrenia susceptibility.

Yamada K, Hattori E, Iwayama Y, Toyota T, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Mori N, Yoshikawa T.

Schizophr Res. 2015 Oct;168(1-2):444-9. doi: 10.1016/j.schres.2015.08.018. Epub 2015 Aug 29.

PMID:
26324334
27.

Genome-wide Association Study of Autism Spectrum Disorder in the East Asian Populations.

Liu X, Shimada T, Otowa T, Wu YY, Kawamura Y, Tochigi M, Iwata Y, Umekage T, Toyota T, Maekawa M, Iwayama Y, Suzuki K, Kakiuchi C, Kuwabara H, Kano Y, Nishida H, Sugiyama T, Kato N, Chen CH, Mori N, Yamada K, Yoshikawa T, Kasai K, Tokunaga K, Sasaki T, Gau SS.

Autism Res. 2016 Mar;9(3):340-9. doi: 10.1002/aur.1536. Epub 2015 Aug 28.

PMID:
26314684
28.

Erratum to: Association study of H2AFZ with schizophrenia in a Japanese case-control sample.

Jitoku D, Yamamoto N, Iwayama Y, Toyota T, Miyagi M, Enokida T, Tasaka Y, Umino M, Umino A, Uezato A, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Kurumaji A, Yoshikawa T, Nishikawa T.

J Neural Transm (Vienna). 2015 Nov;122(11):1619-20. doi: 10.1007/s00702-015-1429-x.

PMID:
26259709
29.

Prognostic value of HLA class I expression in patients with colorectal cancer.

Iwayama Y, Tsuruma T, Mizuguchi T, Furuhata T, Toyota N, Matsumura M, Torigoe T, Sato N, Hirata K.

World J Surg Oncol. 2015 Feb 12;13:36. doi: 10.1186/s12957-015-0456-2.

30.

Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies.

Shimamoto C, Ohnishi T, Maekawa M, Watanabe A, Ohba H, Arai R, Iwayama Y, Hisano Y, Toyota T, Toyoshima M, Suzuki K, Shirayama Y, Nakamura K, Mori N, Owada Y, Kobayashi T, Yoshikawa T.

Hum Mol Genet. 2015 Apr 15;24(8):2409. doi: 10.1093/hmg/ddv011. Epub 2015 Feb 5. No abstract available.

31.

Genetic analysis of the glyoxalase system in schizophrenia.

Bangel FN, Yamada K, Arai M, Iwayama Y, Balan S, Toyota T, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Mori N, Itokawa M, Stork O, Yoshikawa T.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jun 3;59:105-110. doi: 10.1016/j.pnpbp.2015.01.014. Epub 2015 Jan 31.

PMID:
25645869
32.

Utility of Scalp Hair Follicles as a Novel Source of Biomarker Genes for Psychiatric Illnesses.

Maekawa M, Yamada K, Toyoshima M, Ohnishi T, Iwayama Y, Shimamoto C, Toyota T, Nozaki Y, Balan S, Matsuzaki H, Iwata Y, Suzuki K, Miyashita M, Kikuchi M, Kato M, Okada Y, Akamatsu W, Mori N, Owada Y, Itokawa M, Okano H, Yoshikawa T.

Biol Psychiatry. 2015 Jul 15;78(2):116-25. doi: 10.1016/j.biopsych.2014.07.025. Epub 2014 Sep 11.

33.

Exon resequencing of H3K9 methyltransferase complex genes, EHMT1, EHTM2 and WIZ, in Japanese autism subjects.

Balan S, Iwayama Y, Maekawa M, Toyota T, Ohnishi T, Toyoshima M, Shimamoto C, Esaki K, Yamada K, Iwata Y, Suzuki K, Ide M, Ota M, Fukuchi S, Tsujii M, Mori N, Shinkai Y, Yoshikawa T.

Mol Autism. 2014 Oct 6;5(1):49. doi: 10.1186/2040-2392-5-49. eCollection 2014.

34.

Association study of H2AFZ with schizophrenia in a Japanese case-control sample.

Jitoku D, Yamamoto N, Iwayama Y, Toyota T, Miyagi M, Enokida T, Tasaka Y, Umino M, Umino A, Uezato A, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Kurumaji A, Yoshikawa T, Nishikawa T.

J Neural Transm (Vienna). 2015 Jun;122(6):915-23. doi: 10.1007/s00702-014-1332-x. Epub 2014 Nov 13. Erratum in: J Neural Transm (Vienna). 2015 Nov;122(11):1619-20.

PMID:
25392085
35.

Identification of Rare, Single-Nucleotide Mutations in NDE1 and Their Contributions to Schizophrenia Susceptibility.

Kimura H, Tsuboi D, Wang C, Kushima I, Koide T, Ikeda M, Iwayama Y, Toyota T, Yamamoto N, Kunimoto S, Nakamura Y, Yoshimi A, Banno M, Xing J, Takasaki Y, Yoshida M, Aleksic B, Uno Y, Okada T, Iidaka T, Inada T, Suzuki M, Ujike H, Kunugi H, Kato T, Yoshikawa T, Iwata N, Kaibuchi K, Ozaki N.

Schizophr Bull. 2015 May;41(3):744-53. doi: 10.1093/schbul/sbu147. Epub 2014 Oct 20.

36.

Elfn1 recruits presynaptic mGluR7 in trans and its loss results in seizures.

Tomioka NH, Yasuda H, Miyamoto H, Hatayama M, Morimura N, Matsumoto Y, Suzuki T, Odagawa M, Odaka YS, Iwayama Y, Won Um J, Ko J, Inoue Y, Kaneko S, Hirose S, Yamada K, Yoshikawa T, Yamakawa K, Aruga J.

Nat Commun. 2014 Jul 22;5:4501. doi: 10.1038/ncomms5501.

PMID:
25047565
37.

Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies.

Shimamoto C, Ohnishi T, Maekawa M, Watanabe A, Ohba H, Arai R, Iwayama Y, Hisano Y, Toyota T, Toyoshima M, Suzuki K, Shirayama Y, Nakamura K, Mori N, Owada Y, Kobayashi T, Yoshikawa T.

Hum Mol Genet. 2014 Dec 15;23(24):6495-511. doi: 10.1093/hmg/ddu369. Epub 2014 Jul 15. Erratum in: Hum Mol Genet. 2015 Apr 15;24(8):2409.

38.

Sequencing and expression analyses of the synaptic lipid raft adapter gene PAG1 in schizophrenia.

Balan S, Iwayama Y, Yamada K, Toyota T, Ohnishi T, Toyoshima M, Shimamoto C, Ide M, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Yoshikawa T, Maekawa M.

J Neural Transm (Vienna). 2015 Mar;122(3):477-85. doi: 10.1007/s00702-014-1269-0. Epub 2014 Jul 9.

PMID:
25005592
39.

Replication and cross-phenotype study based upon schizophrenia GWASs data in the Japanese population: support for association of MHC region with psychosis.

Saito T, Kondo K, Iwayama Y, Shimasaki A, Aleksic B, Yamada K, Toyota T, Hattori E, Esaki K, Ujike H, Inada T, Kunugi H, Kato T, Yoshikawa T, Ozaki N, Ikeda M, Iwata N.

Am J Med Genet B Neuropsychiatr Genet. 2014 Jul;165B(5):421-7. doi: 10.1002/ajmg.b.32246. Epub 2014 May 29.

PMID:
24888570
40.

Zinc finger protein 804A (ZNF804A) and verbal deficits in individuals with autism.

Anitha A, Thanseem I, Nakamura K, Vasu MM, Yamada K, Ueki T, Iwayama Y, Toyota T, Tsuchiya KJ, Iwata Y, Suzuki K, Sugiyama T, Tsujii M, Yoshikawa T, Mori N.

J Psychiatry Neurosci. 2014 Sep;39(5):294-303.

41.

Defective craniofacial development and brain function in a mouse model for depletion of intracellular inositol synthesis.

Ohnishi T, Murata T, Watanabe A, Hida A, Ohba H, Iwayama Y, Mishima K, Gondo Y, Yoshikawa T.

J Biol Chem. 2014 Apr 11;289(15):10785-96. doi: 10.1074/jbc.M113.536706. Epub 2014 Feb 19.

42.

22q11.2 deletion carriers and schizophrenia-associated novel variants.

Balan S, Iwayama Y, Toyota T, Toyoshima M, Maekawa M, Yoshikawa T.

Br J Psychiatry. 2014;204:398-9. doi: 10.1192/bjp.bp.113.138420. Epub 2014 Jan 30.

PMID:
24482440
43.

Genetic association study between the detected risk variants based upon type II diabetes GWAS and psychotic disorders in the Japanese population.

Kajio Y, Kondo K, Saito T, Iwayama Y, Aleksic B, Yamada K, Toyota T, Hattori E, Ujike H, Inada T, Kunugi H, Kato T, Yoshikawa T, Ozaki N, Ikeda M, Iwata N.

J Hum Genet. 2014 Jan;59(1):54-6. doi: 10.1038/jhg.2013.116. Epub 2013 Nov 7.

PMID:
24196380
44.

Genetic variants on 3q21 and in the Sp8 transcription factor gene (SP8) as susceptibility loci for psychotic disorders: a genetic association study.

Kondo K, Ikeda M, Kajio Y, Saito T, Iwayama Y, Aleksic B, Yamada K, Toyota T, Hattori E, Ujike H, Inada T, Kunugi H, Kato T, Yoshikawa T, Ozaki N, Iwata N.

PLoS One. 2013 Aug 13;8(8):e70964. doi: 10.1371/journal.pone.0070964. eCollection 2013.

45.

Association of decreased prefrontal hemodynamic response during a verbal fluency task with EGR3 gene polymorphism in patients with schizophrenia and in healthy individuals.

Nishimura Y, Takizawa R, Koike S, Kinoshita A, Satomura Y, Kawasaki S, Yamasue H, Tochigi M, Kakiuchi C, Sasaki T, Iwayama Y, Yamada K, Yoshikawa T, Kasai K.

Neuroimage. 2014 Jan 15;85 Pt 1:527-34. doi: 10.1016/j.neuroimage.2013.08.021. Epub 2013 Aug 17.

PMID:
23962955
46.

Population-specific haplotype association of the postsynaptic density gene DLG4 with schizophrenia, in family-based association studies.

Balan S, Yamada K, Hattori E, Iwayama Y, Toyota T, Ohnishi T, Maekawa M, Toyoshima M, Iwata Y, Suzuki K, Kikuchi M, Yoshikawa T.

PLoS One. 2013 Jul 25;8(7):e70302. doi: 10.1371/journal.pone.0070302. Print 2013.

47.

Lack of association of EGR2 variants with bipolar disorder in Japanese population.

Balan S, Yamada K, Iwayama Y, Toyota T, Ohnishi T, Maekawa M, Toyoshima M, Iwata Y, Suzuki K, Kikuchi M, Ujike H, Inada T, Kunugi H, Ozaki N, Iwata N, Nanko S, Kato T, Yoshikawa T.

Gene. 2013 Sep 10;526(2):246-50. doi: 10.1016/j.gene.2013.05.055. Epub 2013 Jun 4.

PMID:
23747400
48.

A population-specific uncommon variant in GRIN3A associated with schizophrenia.

Takata A, Iwayama Y, Fukuo Y, Ikeda M, Okochi T, Maekawa M, Toyota T, Yamada K, Hattori E, Ohnishi T, Toyoshima M, Ujike H, Inada T, Kunugi H, Ozaki N, Nanko S, Nakamura K, Mori N, Kanba S, Iwata N, Kato T, Yoshikawa T.

Biol Psychiatry. 2013 Mar 15;73(6):532-9. doi: 10.1016/j.biopsych.2012.10.024. Epub 2012 Dec 11.

49.

Human myo-inositol monophosphatase 2 rescues the nematode thermotaxis mutant ttx-7 more efficiently than IMPA1: functional and evolutionary considerations of the two mammalian myo-inositol monophosphatase genes.

Ohnishi T, Tanizawa Y, Watanabe A, Nakamura T, Ohba H, Hirata H, Kaneda C, Iwayama Y, Arimoto T, Watanabe K, Mori I, Yoshikawa T.

J Neurochem. 2013 Mar;124(5):685-94. doi: 10.1111/jnc.12112. Epub 2012 Dec 26.

50.

Brain region-specific altered expression and association of mitochondria-related genes in autism.

Anitha A, Nakamura K, Thanseem I, Yamada K, Iwayama Y, Toyota T, Matsuzaki H, Miyachi T, Yamada S, Tsujii M, Tsuchiya KJ, Matsumoto K, Iwata Y, Suzuki K, Ichikawa H, Sugiyama T, Yoshikawa T, Mori N.

Mol Autism. 2012 Nov 1;3(1):12. doi: 10.1186/2040-2392-3-12.

Supplemental Content

Loading ...
Support Center